Tech Company Financing Transactions
Biomatter Funding Round
Astanor Ventures, Inventure and Metaplanet invested in a $18 million Series A funding round for Biomatter. The round was announced on 11/11/2026.
Transaction Overview
Company Name
Announced On
11/11/2026
Transaction Type
Venture Equity
Amount
$18,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to expand its commercial team and U.S. presence, and continue investing in its computational platform and proprietary enzyme dataset.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Rinktines str. 5-101
Vilnius, LT-09234
Lithuania
Vilnius, LT-09234
Lithuania
Phone
Undisclosed
Website
Email Address
Overview
Biomatter is an enzyme design company creating novel enzymes for health and sustainable manufacturing applications. The company has developed an AI-first platform that addresses limitations of legacy engineering approaches to unlock completely new horizons for enzyme design and development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Laurynas Karpus
Chief Financial Officer
Hugo Nordström
Chief Scientific Officer
Linas Zakrys
Chief Technical Officer
Irmantas Rokaitis
Browse more venture capital transactions:
Prev: 11/11/2026: Operand venture capital transaction
Next: 11/11/2026: Nidus venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs